SeaStar Medical Holding Corporation (ICU) Revenue History
Annual and quarterly revenue from 2020 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ICU Revenue Growth
ICU Revenue Analysis (2020–2024)
As of May 8, 2026, SeaStar Medical Holding Corporation (ICU) generated trailing twelve-month (TTM) revenue of $881,000, reflecting explosive growth of +169.1% year-over-year. The most recent quarter (Q3 2025) recorded $183,000 in revenue, down 45.9% sequentially.
Looking at the longer-term picture, ICU's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $135,000 in 2024, representing a new all-time high.
When compared to Healthcare sector peers including NKTR (-43.9% YoY), TPVG, and AKBA (+25.7% YoY), ICU has outperformed the peer group in terms of revenue growth. Compare ICU vs NKTR →
ICU Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ICUCurrent | $881,000 | +169.1% | - | -13216.3% | |
 NKTR | $55M | -43.9% | -18.4% | -236.8% | |
 TPVG | $97M | - | - | 77.9% | |
 AKBA | $236M | +25.7% | -4.3% | 9.9% | |
 CPRX | $589M | +19.8% | +37.7% | 43.8% | |
 XOMA | $52M | +126.2% | +12.2% | 21.8% |
ICU Historical Revenue Data (2020–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $135K | - | $135K | 100.0% | $-17,842,000 | -13216.3% |
| 2023 | $0 | - | $0 | - | $-14,210,000 | - |
| 2022 | $0 | - | $0 | - | $-11,609,000 | - |
| 2021 | $0 | - | $0 | - | $-4,449,000 | - |
| 2020 | $0 | - | $0 | - | $-6,453,000 | - |
See ICU's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ICU Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ICU vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonICU — Frequently Asked Questions
Quick answers to the most common questions about buying ICU stock.
Is ICU's revenue growth accelerating or slowing?
ICU revenue is accelerating at +169.1% year-over-year, exceeding the 5-year CAGR of N/A. TTM revenue reached $881000.00. Growth momentum has increased versus prior periods.
What is ICU's long-term revenue growth rate?
SeaStar Medical Holding Corporation's 5-year revenue CAGR of N/A reflects the sustained expansion pattern. Current YoY growth of +169.1% is above this long-term average.
How is ICU's revenue distributed by segment?
ICU reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2020-2024 are available for download. Segment mix reveals concentration and diversification trends.